PIK3CA and glioblastoma: Among these, PIK3CA was found to be statistically significant (P ≤ 0.05), with higher expression levels of PIK3CA (HR 0.05, P = 0.05) correlating with worse overall survival (OS) in GBM patients (Fig. 6a).